type_of_cancer: prad
cancer_study_identifier: prad_su2c_2019
name: Metastatic Prostate Adenocarcinoma (SU2C/PCF Dream Team, PNAS 2019)
short_name: Prostate (SU2C 2019)
description: Whole exome sequencing of 444 castrate resistant prostate cancer tumor/normal pairs. SU2C-PCF Dream Team: Precision Therapy for Advanced Prostate Cancer.
pmid: 31061129
citation: Abida et al. PNAS 2019
